[language-switcher]
John M. Cunningham, MD, is an internationally known expert in the treatment and research of childhood cancers and blood diseases. He has particular expertise in treating leukemia, lymphoma, immunodeficiencies,
sickle cell disease and thalassemia. He is a recognized leader in the field of pediatric stem cell transplantation and has developed novel uses for this life-saving treatment. An active researcher, Dr. Cunningham is studying the biology and therapy of hemoglobinopathies,
hematopoiesis and the leukemia stem cell, transcriptional mechanisms operative during the development of vertebrate organisms, and the development of clinical trials for the treatment of leukemia and genetic diseases. Over his distinguished career, Dr. Cunningham's
research has received support from the National Heart, Lung, and Blood Institute, the American Society of Hematology, and other prominent scientific organizations. He is a member of the scientific council of the American Cancer Society, and a member of the
editorial board of The Oncologist.
We’d love to hear from you. Here’s how you can reach us.
General Inquiries
Forbes Middle East is a licensee of Forbes Media and extends the Forbes brand of journalism across the Arab world. Forbes Middle East’s distinctive editorial style attracts a readership of Arab leaders, entrepreneurs, C-level executives, government officials and investors united by a belief in the spirit of free enterprise and entrepreneurial values.Across the region, Forbes Middle East sets the pace for preemptive business journalism. By uncovering trends and anticipating opportunities in the regional marketplace, each monthly issue brings top executives the information critical to their success – in both Arabic and English language editions. The magazine researches and publishes original rankings, based on methodologies set by Forbes Media.